Date: 2nd -4th November, 2016

Location: Shahid Beheshti University, Tehran, Iran

Audience: Endocrinologists, Gynecologists and GPs

Products: Apo-Metformin & Apo-Glyburide

The congress was held at Shahid Beheshti University in Tehran on 2nd to 4th November, 2016 and  has created an opportunity to give awareness to doctors particularly endocrinologists and gynecologists about Apo-Metformin and Apo-Glyburide's return. 



The received feedback from physicians was amazing. They mostly have found Apo-Metformin as a first choice in treating diabetes.



According to their report, Apo-Metformin has the least gastrointestinal side effects and highest efficacy among all available metformins in the market and has been reputable and well-known by both physicians and patients.